James C. Greenwood
Chairman, BVGH Board of Directors; Past President & CEO, Biotechnology Innovation Organization; DLA Piper
Prior to joining DLA Piper as an advisor to clients on a variety of legislative, regulatory, and policy issues impacting healthcare and the life sciences sectors, Jim led and more than doubled the size of the Biotechnology Innovation Organization (BIO) as its CEO and President for sixteen years.
Before joining BIO, Jim represented Pennsylvania's Eighth Congressional District from 1993 to 2005. During his time in Congress, he was a senior member of the Energy and Commerce Committee and widely viewed as a leader on healthcare and the environment. He crafted legislation to reform the Food and Drug Administration, to create the pediatric exclusivity and pediatric autism research acts, and he led the fight in Congress to allow stem cell research to be conducted by US scientists to treat disease.
From 2001 to 2004, Jim served as chair of the House Energy and Commerce Committee's Subcommittee on Oversight and Investigations. In this role, he led investigations into corporate governance at Enron, Global Crossing, and WorldCom, and reform at the NIH and in waste and fraud in federal government agencies. Before his election to Congress, from 1981 to 1992, Jim served in the Pennsylvania General Assembly, including six years in the State House and six years in the State Senate.